MedRegen LLC

Industry · 5 registered clinical trials — 3 currently recruiting.

Status	Trial	Phase	Started
Not Yet Recruiting	MRG-001 in Patients With Amyotrophic Lateral Sclerosis Amyotrophic Lateral Sclerosis, Lou Gehrig Disease, Motor Neuron Disease	Phase 2	2025-07-01
Not Yet Recruiting	MRG-001 as an Immunoregulatory and Regenerative Therapy for ARDS Patients Acute Respiratory Distress Syndrome, Respiratory Failure, Respiratory Distress Syndrome	Phase 2	2024-12-01
Not Yet Recruiting	MRG-001 in Patients With Alcoholic Hepatitis Alcoholic Hepatitis, Acute Alcoholic Hepatitis	Phase 2	2024-09-01
Completed	Safety and Efficacy of MRG-001 in Wound Healing in Abdominoplasty Patients Wound of Skin, Abdominal Wound	Phase 2	2023-11-20
Unknown	MRG-001 as an Immunoregulatory and Regenerative Therapy for COVID-19 Patients COVID-19, ARDS, Human, Stem Cells	Phase 2	2021-12-01